查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049670

活細胞成像市場報告：按產品、應用、技術和地區分類（2026-2034 年）

Live Cell Imaging Market Report by Product, Application, Technology (Time-Lapse Microscopy, Fluorescence Recovery after Photobleaching, Fluorescence Resonance Energy Transfer, High Content Screening, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球活細胞成像市場規模達27億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以6.98%的複合年成長率成長，到2034年達到50億美元。北美憑藉其先進的技術基礎設施和強大的研發實力，正引領市場發展。推動市場成長的因素包括：細胞研究投資的激增、影像系統的技術進步、人工智慧（AI）和機器學習（ML）的日益融合、藥物研發需求的成長、個人化醫療需求的擴大、政府對生命科學領域的投入增加以及實驗室工作流程的自動化。

活細胞成像技術在藥物研發領域的日益普及是市場成長的關鍵驅動力。該技術使科學家能夠即時觀察細胞對候選藥物化合物的反應，從而加速有效治療方法的發現。這種即時監測有助於更有效地了解藥物的作用機制和毒性特徵，最大限度地降低藥物研發的時間和成本。此外，成像技術的不斷進步，包括高解析度顯微鏡和螢光探針，使得對細胞功能的觀察更加準確和全面，加深了我們對複雜生物機制的理解。人工智慧和自動化技術的引入進一步增強了這些能力，提高了研究和診斷的效率和準確性。此外，癌症、心臟病和神經退化性疾病等慢性疾病的日益普遍也推動了對先進成像技術的需求。活細胞影像技術使研究人員和醫療保健專業人員能夠觀察疾病進展、細胞間相互作用以及對治療的反應，在開發針對這些複雜疾病的更有效、更具標靶性的治療方法方面發揮著至關重要的作用。

活細胞成像市場的發展趨勢：

成像系統對先進環境控制的需求

對能夠確保長期細胞監測最佳條件的先進環境控制系統的需求日益成長，正對市場產生積極影響。隨著研究越來越依賴長期檢測來監測活細胞的即時變化，穩定的溫度、濕度和氣體成分至關重要。具備精確環境控制能力的影像系統有助於模擬體內環境，確保細胞在實驗過程中維持自然行為。這增強了結果的生物學意義，並最大限度地減少了外部環境變化導致的數據變異性。能夠在不影響細胞活力的情況下進行長期成像，使得研究更加複雜和深入。 2024年，ONI推出了Stage Top Incubator，這是一款旨在增強Nanoimager活細胞成像的精確環境控制系統。此培養箱能夠維持溫度、二氧化碳和濕度，模擬體內環境，適用於長期檢測。它還支援標準玻片和培養皿，提高了實驗的靈活性和生物學有效性。

加大對基於細胞的檢測方法的投資

高度依賴活細胞檢測的平台正獲得大量資金，尤其是在免疫腫瘤學、感染疾病和代謝紊亂等領域。這些檢測旨在展示細胞隨時間變化的行為，包括細胞遷移、細胞間相互作用以及對刺激的反應——這些特性無法透過靜態成像或終點評估來捕捉。投資人正在尋找能夠與藥物研發管線同步發展，同時又能確保準確性的檢驗技術。活細胞成像滿足這些要求，尤其適用於對速度、清晰度和一致性要求極高的多重檢測環境。因此，新興的新創公司和中型生物技術公司從一開始就將成像功能融入其核心服務中。基於活細胞的平台在吸引早期投資方面日益成長的重要性，也推動了擴充性的自動化成像系統的應用。

更便捷地取得高階成像技術

隨著功能更先進、更緊湊且價格更親民的活細胞成像系統不斷湧現，活細胞成像市場正在蓬勃發展。傳統上，由於規模龐大、技術複雜且成本高昂，先進的活細胞成像技術僅限於資金雄厚的機構使用。而近期的技術進步旨在讓更多用戶，包括小規模實驗室、學術機構和新興生物技術公司，都能使用這些工具。這種轉變正在加速人們參與詳細的細胞研究和功能評估中，尤其是在免疫療法、T細胞研究和再生醫學等領域。這些易於使用的系統透過降低經濟和操作門檻，擴大了使用者群體，提高了活細胞成像技術的普及率。 2025年，布魯克公司宣布推出Beacon Discovery™，這是一款小巧且價格親民的活細胞功能分析系統。該系統基於布魯克公司的OEP技術，可透過機器學習（ML）自動化實現即時、多參數的單細胞分析。 Beacon Discovery™旨在促進學術界和生物技術領域的廣泛應用，支持免疫療法、T細胞受體（TCR）發現和再生醫學等領域的研究。

活細胞成像市場成長要素：

慢性病和感染疾病率上升

隨著慢性疾病（尤其是癌症、心臟病和神經退化性疾病）的日益普遍，對活細胞成像等先進技術的需求也日益成長。這些疾病通常涉及複雜的細胞活動，因此準確、即時的監測對於了解疾病進展和治療反應至關重要。活細胞成像技術使科學家能夠在各種治療方案下觀察細胞變化，從而支持標靶治療的進展並增強臨床試驗的決策。其捕捉動態過程的能力對於發現更有效、創傷更小的治療方法至關重要。世界衛生組織 (WHO) 估計，到 2050 年，全球將新增超過 3,500 萬例癌症病例，凸顯了支持早期檢測和治療管理的資源需求極為旺盛。隨著醫療保健的重點轉向疾病管理和個人化治療方案，活細胞成像正成為研究和臨床實踐中不可或缺的關鍵要素。

策略聯盟

成像技術開發人員之間的合作對於整合互補功能和建構一致的系統至關重要。此類夥伴關係催生了整合平台，這些平台提供先進的成像功能、便捷的自動化和擴展的功能。這些解決方案結合了硬體進步和先進的計算技術，使研究人員能夠以更高的清晰度、速度和精度執行複雜的 3D 成像任務。此外，這些整合系統簡化了設定並提高了工作流程效率，使更多用戶能夠使用先進的成像技術。隨著越來越多的公司合作開發更完善的解決方案，活細胞成像市場對那些需要卓越產品特性和高解析度 3D 細胞觀察的研究領域越來越有吸引力。順應這一趨勢，CrestOptics 和 Leica Microsystems 於 2024 年宣佈建立戰略合作夥伴關係，將 CrestOptics 的 CICERO 旋轉盤單元整合到 Leica 的 THUNDER Imager 細胞旋轉盤系統中。此次合作將 CICERO 的緊湊型高解析度共聚焦成像與 THUNDER 的先進計算透明化和自動化工具相結合，從而擴展了對複雜生物樣本進行高效 3D 活細胞成像的應用範圍。

培訓和教育應用的擴展

活細胞成像技術在教育和培訓領域的日益普及是推動市場成長的關鍵因素。隨著細胞生物學、藥理學和生物醫學課程在科研機構和大學中的擴展，對先進成像技術的需求不斷成長，以培養未來的科學家和醫學專業人員。活細胞成像技術使學生和研究人員能夠即時觀察細胞活動，從而獲得使用先進技術的重要實務經驗。此外，這項技術正被納入醫學和研究專業人員的培訓計畫和研討會中，有助於加深對細胞動力學和疾病進展的理解。隨著教育機構增加對先進成像技術的投入以提升學習體驗，活細胞成像市場正受益於用戶群的擴大和這些工具應用的日益普及。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球活細胞影像市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 裝置
  • 消耗品
  • 軟體

第7章 市場區隔：依應用領域分類

  • 細胞生物學
  • 發育生物學
  • 幹細胞與藥物發現
  • 其他

第8章 市場區隔：依技術分類

  • 延時顯微鏡
  • 光漂白後螢光恢復（FRAP）
  • 螢光共振能量轉移（FRET）
  • 高內涵篩檢（HCS）
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Becton Dickinson and Company
    • Carl Zeiss AG
    • Leica Microsystems（Danaher Corporation）
    • Merck KGaA
    • Nikon Instruments Inc
    • Olympus Corporation
    • PerkinElmer Inc
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A4101

The global live cell imaging market size reached USD 2.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.0 Billion by 2034, exhibiting a growth rate (CAGR) of 6.98% during 2026-2034. North America dominates the market because of state-of-the-art technological infrastructure and strong research and development (R&D) initiatives. Surging cell-based research investments, technological advancements in imaging systems, increasing artificial intelligence (AI) and machine learning (ML) integration, growing demand in drug discovery, the escalating demand for personalized medicine, the rise in government funding for life sciences, and the automation of laboratory workflows are some of the factors propelling the market growth.

The rising adoption of live cell imaging in drug discovery is a crucial factor bolstering the market growth. It allows scientists to observe cellular reactions to prospective drug compounds instantaneously, speeding up the discovery of efficient therapies. This real-time monitoring aids in comprehending drug mechanisms and toxicity profiles more effectively, minimizing the duration and expenses of drug development. Moreover, ongoing advancements in imaging technologies, including high-resolution microscopes and fluorescent probes, are allowing for more accurate and comprehensive observations of cellular functions, resulting in improved understanding of intricate biological mechanisms. The incorporation of AI and automation further boosts these abilities, enhancing efficiency and precision in research and diagnostics. Besides this, the growing prevalence of chronic illnesses like cancer, heart diseases, and neurodegenerative disorders is driving the need for sophisticated imaging technologies. Live cell imaging enables researchers and healthcare providers to examine disease progression, interactions between cells, and responses to treatments, essential for creating more effective and targeted therapies for these intricate diseases.

Live Cell Imaging Market Trends:

Demand for Advanced Environmental Control in Imaging Systems

The growing need for sophisticated environmental control systems that ensure optimal conditions for extended cellular monitoring is positively influencing the market. As studies increasingly depend on prolonged assays to monitor real-time alterations in living cells, stable temperature, humidity, and gas composition become crucial. Imaging systems that incorporate accurate environmental control aid in mimicking in vivo conditions, guaranteeing that cells act naturally during the experiment. This enhances the biological significance of results and minimizes data variability due to external changes. The capacity to perform extended imaging sessions without affecting cell viability also allows for more intricate and content-rich investigations. In 2024, ONI launched the Stage Top Incubator, a precision environmental control system designed to enhance live-cell imaging on the Nanoimager. It maintained temperature, CO2, and humidity to simulate in vivo-like conditions for extended assays. The incubator supported standard slides and dishes, improving experimental versatility and biological relevance.

Growing Investment in Cell-Based Assays

Capital is being directed towards platforms that depend significantly on live cell assays, particularly within fields like immuno-oncology, infectious diseases, and metabolic disorders. These tests are intended to demonstrate behavior over time like cell movement, cell-cell interactions, and reactions to stimuli, which static imaging or endpoint assessments fail to capture. Investors seek validation technologies that can grow alongside drug pipelines while still ensuring accuracy. Live cell imaging meets that requirement and is especially beneficial for multiplexed assay settings where rapidity, clarity, and consistency are essential. As a result, emerging startups and medium-sized biotech companies are incorporating imaging functionalities into their essential services from the outset. The growing significance of live-cell-based platforms in attracting early-stage investment also motivates the implementation of scalable, automated imaging systems.

Increasing Accessibility of High-End Imaging Technologies

The market for live cell imaging is growing as more compact, affordable systems with advanced features become available. Traditionally, advanced live cell imaging technologies were constrained to affluent organizations because of their scale, intricacy, and expense. Recent advancements are aiming at increasing the accessibility of these tools to a broader array of users, encompassing smaller research laboratories, academic institutions, and nascent biotech companies. This change encourages wider involvement in detailed cellular studies and functional evaluations, particularly in areas like immunotherapy, T cell investigation, and regenerative medicine. These accessible systems widen the user base and boost the adoption rate of live cell imaging technologies by minimizing financial and operational obstacles. In 2025, Bruker announced the launch of Beacon Discovery(TM), a compact and affordable live single-cell functional analysis system. Built on Bruker's OEP technology, it enables real-time, multi-parameter single-cell studies with ML-driven automation. Designed for broader access in academia and biotech, it supports immunotherapy, TCR discovery, and regenerative medicine research.

Live Cell Imaging Market Growth Drivers:

Rising Prevalence of Chronic and Infectious Diseases

The increasing cases of chronic diseases, particularly cancer, heart conditions, and neurodegenerative illnesses, is driving the need for sophisticated technologies, such as live cell imaging. These illnesses usually entail intricate cellular activities that necessitate accurate, immediate monitoring to comprehend advancement and therapeutic reaction. Live cell imaging allows scientists to observe cellular alterations under different therapeutic scenarios, aiding the advancement of targeted therapies and enhancing decision-making in clinical studies. Its capability to capture dynamic processes makes it crucial for discovering more effective, less invasive treatment methods. The World Health Organization (WHO) estimates that more than 35 million new cancer cases will be reported by 2050, emphasizing the critical demand for resources that aid in early detection and treatment oversight. With an increasing emphasis on disease management and tailored treatment approaches in healthcare, live cell imaging emerges as an essential element in research and clinical settings.

Strategic Collaborations

Collaborative alliances among imaging technology creators are crucial for integrating complementary capabilities into cohesive systems. These partnerships lead to cohesive platforms that provide enhanced imaging capabilities, convenient automation, and expanded features. By combining hardware advancements with sophisticated computational technologies, these solutions allow researchers to perform intricate 3D imaging tasks with enhanced clarity, speed, and accuracy. These integrated systems also simplify setup and enhance workflow efficiency, making advanced imaging more attainable for a broader spectrum of users. With an increasing number of companies collaborating to create improved solutions, the live cell imaging market benefiting from superior product features and heightened attractiveness in research fields demanding high-resolution, 3D cellular examination. In line with this trend, in 2024, CrestOptics and Leica Microsystems announced a strategic partnership to integrate CrestOptics' CICERO spinning disk unit into Leica's THUNDER Imager Cell Spinning Disk system. This collaboration combined CICERO's compact, high-resolution confocal imaging with THUNDER's advanced computational clearing and automation tools. It expanded access to efficient 3D live-cell imaging for complex biological samples.

Enhanced Training and Educational Applications

The increasing adoption of live cell imaging in educational and training environments is a crucial factor impelling the market growth. With the expansion of curricula in cell biology, pharmacology, and biomedical sciences at research institutions and universities, there is a rise in the demand for advanced imaging technologies to educate future scientists and healthcare professionals. Live cell imaging enables students and researchers to watch cellular activities as they happen, offering essential practical experience with advanced technology. Moreover, this technology is being integrated into training programs and workshops for medical and research experts, enhancing their comprehension of cell dynamics and disease processes. With educational institutions increasingly investing in advanced imaging technologies to improve learning experiences, the live cell imaging market is benefiting from a broader user base and higher adoption of these tools.

Live Cell Imaging Market Segmentation:

The publisher provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2026-2034. Our report has categorized the market based on product, application, and technology.

Breakup by Product:

  • Equipment
  • Consumable
  • Software

Equipment accounts for the majority of the market share

The equipment segment is driven by the continuous advancements in imaging technology, enabling higher resolution and improved accuracy in live cell analysis. Innovations such as multi-photon microscopes, fluorescence imaging, and super-resolution microscopy are enhancing researchers' ability to observe intricate cellular processes in real-time. The demand for automated, user-friendly systems is also propelling growth, as laboratories seek to streamline workflows and increase throughput. Additionally, the rising focus on drug discovery, cancer research, and regenerative medicine has led to higher adoption of advanced imaging equipment to support these fields. Increasing investments in life sciences research, coupled with government funding for scientific innovations, are further boosting the demand for state-of-the-art imaging systems. The growing need for precise, non-invasive imaging tools in clinical diagnostics and biotechnology applications is also playing a crucial role in driving the equipment segment, making it an essential part of the live cell imaging market's expansion.

Breakup by Application:

  • Cell Biology
  • Developmental Biology
  • Stem Cell and Drug Discovery
  • Others

Cell biology holds the largest share of the industry

As per the live cell imaging market overview, the cell biology segment is driven by the increasing demand for real-time visualization of cellular processes, which is critical for understanding cell function, signaling pathways, and interactions. Researchers rely on live cell imaging to study complex biological phenomena such as cell differentiation, migration, and apoptosis, which are central to cell biology. Advancements in imaging technologies, such as high-resolution microscopes and advanced fluorescence techniques, are providing clearer, more detailed cellular images, further driving this segment. Additionally, the rising focus on cancer research, regenerative medicine, and stem cell therapies has fueled the need for accurate, dynamic cell monitoring. Increased government funding for biological research and growing pharmaceutical industry investments in drug development are also bolstering the live cell imaging market revenue.

Breakup by Technology:

  • Time-Lapse Microscopy
  • Fluorescence Recovery after Photobleaching (FRAP)
  • Fluorescence Resonance Energy Transfer (FRET)
  • High Content Screening (HCS)
  • Others

Fluorescence recovery after photobleaching (FRAP) represents the leading market segment

The fluorescence recovery after photobleaching (FRAP) segment is driven by the growing demand for advanced techniques to study molecular dynamics within live cells. FRAP allows researchers to monitor protein mobility, binding kinetics, and membrane fluidity in real time, which is crucial in understanding cellular processes like signal transduction and gene expression. Increasing applications in drug discovery, particularly in evaluating the effects of new therapies on protein interactions, are boosting the use of this technique. Technological advancements, such as higher-resolution imaging systems and improved photobleaching tools, have made FRAP more accessible and precise. Additionally, the rising interest in studying diseases at the molecular level, including cancer and neurodegenerative disorders, is fueling its adoption.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America leads the market, accounting for the largest live cell imaging market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for live cell imaging.

As per the live cell imaging market forecast, the North America's regional market is driven by the strong presence of advanced healthcare infrastructure and a robust pharmaceutical industry, which heavily invests in research and development (R&D). The increasing focus on drug discovery, personalized medicine, and cancer research has elevated the demand for live cell imaging technologies. Additionally, technological advancements in imaging systems, such as high-resolution microscopes and advanced fluorescence techniques, are supporting market growth. Government initiatives and funding for life science research, particularly in the United States, further fuel this expansion. Moreover, the presence of key market players and collaborations between research institutions and pharmaceutical companies enhance the live cell imaging market's value.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the live cell imaging industry include Becton Dickinson and Company (BD), Carl Zeiss AG, Leica Microsystems (Danaher Corporation), Merck KGaA, Nikon Instruments Inc., Olympus Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • The key live cell imaging companies are focusing on innovation and strategic collaborations to stay competitive. They are heavily investing in research and development (R&D) to introduce advanced imaging technologies with higher resolution and real-time monitoring capabilities. These companies are also integrating AI and ML into their imaging platforms to enhance data analysis and improve accuracy. Partnerships with academic institutions and research organizations are becoming more common, helping to accelerate product development and expand application areas, particularly in drug discovery and personalized medicine. As per the live cell imaging market research report, companies are expanding their product portfolios through acquisitions and collaborations, allowing them to offer comprehensive solutions for various research needs.

Key Questions Answered in This Report

  • 1.What was the size of the global live cell imaging market in 2025?
  • 2.What is the expected growth rate of the global live cell imaging market during 2026-2034?
  • 3.What are the key factors driving the global live cell imaging market?
  • 4.What has been the impact of COVID-19 on the global live cell imaging market?
  • 5.What is the breakup of the global live cell imaging market based on the product?
  • 6.What is the breakup of the global live cell imaging market based on the application?
  • 7.What is the breakup of the global live cell imaging market based on the technology?
  • 8.What are the key regions in the global live cell imaging market?
  • 9.Who are the key players/companies in the global live cell imaging market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Live Cell Imaging Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Consumable
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Cell Biology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Developmental Biology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Stem Cell and Drug Discovery
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Time-Lapse Microscopy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Fluorescence Recovery after Photobleaching (FRAP)
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Fluorescence Resonance Energy Transfer (FRET)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 High Content Screening (HCS)
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Becton Dickinson and Company
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Carl Zeiss AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Leica Microsystems (Danaher Corporation)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Merck KGaA
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Nikon Instruments Inc
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Olympus Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 PerkinElmer Inc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Thermo Fisher Scientific Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Live Cell Imaging Market: Major Drivers and Challenges
  • Figure 2: Global: Live Cell Imaging Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Live Cell Imaging Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Live Cell Imaging Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Live Cell Imaging Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Live Cell Imaging Market: Breakup by Technology (in %), 2025
  • Figure 7: Global: Live Cell Imaging Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Live Cell Imaging (Equipment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Live Cell Imaging (Equipment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Live Cell Imaging (Consumable) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Live Cell Imaging (Consumable) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Live Cell Imaging (Software) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Live Cell Imaging (Software) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Live Cell Imaging (Cell Biology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Live Cell Imaging (Cell Biology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Live Cell Imaging (Developmental Biology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Live Cell Imaging (Developmental Biology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Live Cell Imaging (Stem Cell and Drug Discovery) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Live Cell Imaging (Stem Cell and Drug Discovery) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Live Cell Imaging (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Live Cell Imaging (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Live Cell Imaging (Time-Lapse Microscopy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Live Cell Imaging (Time-Lapse Microscopy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Live Cell Imaging (Fluorescence Recovery after Photobleaching-FRAP) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Live Cell Imaging (Fluorescence Recovery after Photobleaching-FRAP) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Global: Live Cell Imaging (Fluorescence Resonance Energy Transfer-FRET) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Global: Live Cell Imaging (Fluorescence Resonance Energy Transfer-FRET) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Global: Live Cell Imaging (High Content Screening-HCS) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Global: Live Cell Imaging (High Content Screening-HCS) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Global: Live Cell Imaging (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Global: Live Cell Imaging (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: North America: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: North America: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: United States: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: United States: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Canada: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Canada: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Asia-Pacific: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Asia-Pacific: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: China: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: China: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Japan: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Japan: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: India: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: India: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: South Korea: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: South Korea: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Australia: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Australia: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Indonesia: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Indonesia: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Others: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Others: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Europe: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Europe: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Germany: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Germany: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: France: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: France: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: United Kingdom: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: United Kingdom: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Italy: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Italy: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Spain: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Spain: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Russia: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Russia: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Others: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Others: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Latin America: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Latin America: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Brazil: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Brazil: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 74: Mexico: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 75: Mexico: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 76: Others: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 77: Others: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 78: Middle East and Africa: Live Cell Imaging Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 79: Middle East and Africa: Live Cell Imaging Market: Breakup by Country (in %), 2025
  • Figure 80: Middle East and Africa: Live Cell Imaging Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Global: Live Cell Imaging Industry: SWOT Analysis
  • Figure 82: Global: Live Cell Imaging Industry: Value Chain Analysis
  • Figure 83: Global: Live Cell Imaging Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Live Cell Imaging Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Live Cell Imaging Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Live Cell Imaging Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 4: Global: Live Cell Imaging Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 5: Global: Live Cell Imaging Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Live Cell Imaging Market: Competitive Structure
  • Table 7: Global: Live Cell Imaging Market: Key Players